Startups
nPhase.ai unifies end-to-end clinical research data on one shared model: UDMS for data management, SCE for submission-ready output. See how it works.
Overview
Location
United States
Total raised
$30M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 3, 2026 | nPhase Raises $30 Million Series D Led By Viking Global Investors To Expand AI-Native Clinical Data Platform | nPhase has raised $30 million in Series D funding led by Viking Global Investors to expand its AI-native clinical data platform for pharmaceutical companies and contract research organizations. The financing marks nPhase’s first equity rais... |
| Nov 2, 2026 | nPhase Raises $30M to Scale AI-Native Clinical Data Fabrics and Agentic Workflows for Life Sciences | What You Should Know Clinical research data platform provider nPhase, Inc., announced the closing of a $30M Series D financing round led by Viking Global Investors. The equity financing represents nPhase’s first institutional equity capital... |
Reviews 0
FAQ about End
How much funding has End raised?
End has raised $30M in total across 1 funding round.
What has the press written about End?
Parsers VC has collected 3 articles mentioning End, among them “nPhase Raises $30 Million Series D Led By Viking Global Investors To Expand AI-Native Clinical Data Platform” (Nov 3, 2026) and “nPhase Raises $30M to Scale AI-Native Clinical Data Fabrics and Agentic Workflows for Life Sciences” (Nov 2, 2026).
Is End still active?
Yes, End is active; its latest activity on Parsers VC dates from Nov 3, 2026.